To define whether the aIL-15 antibody might interfere ex vivo with the release of perforin in CeD intestinal mucosa, biopsies from ten untreated CeD patients were cultured in the presence or absence of an aIL-15 antibody. Here, PRF1 is linked to cranioectodermal dysplasia.